MT-ND6 and Alzheimer disease: The transcription ratio was significantly increased in non-diabetic AD patients relative to non-diabetic NCI (MT-ND1 p = 0.0427, MT-ND6 p = 0.0052), and was again found unchanged in diabetic AD (Fig. 4B).